NEW YORK, NY / ACCESSWIRE / Mar 5, 2014 / Recent medical studies have linked low-T testosterone therapy products like AndroGel and Axiron to serious cardiovascular health problems such as heart attack ...

AbbVie’s former blockbuster testosterone-replacement treatment AndroGel will be at the center of a class action lawsuit set to go to trial this year, alleging, in short, that previously healthy men ...

Abbott Laboratories and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claim in lawsuits. Their complaints, filed in ...

First came the drug company ads aimed at older men. Feeling tired, irritable, lost your sex drive? Try our testosterone product. Then came the response ads from trial lawyers. Suffered a heart attack ...

Makers of testosterone drugs must change the products’ labels to clarify that they are approved for only certain disorders, not to help men deal with aging, U.S. regulators said. Uses listed for the ...

(AP) — The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective ...

YONKERS, N.Y., May 20 (UPI) -- Investigators at Consumer Reports say the directions for testosterone gel say the gel is flammable until dry and avoid smoking or an open flame until dry. Consumer ...

AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...

(Bloomberg) — Abbott Laboratories and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their ...

I often bristle at Big Pharma critics who claim that the industry invents diseases. As I have discussed previously, you can’t invent a disease unless there’s a large conspiracy of Big Pharma, the FDA, ...

Thousands of federal lawsuits alleging harm from AbbVie’s AndroGel are on the cusp of being settled, marking the end of a long legal saga about the safety of testosterone therapy and the marketing ...